Previously recorded as Exonoid Medical Devices Ltd. (to 2017)
26 patents currently held
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Feb 2032. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Feb 2032
Next term end
11
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jan 2038 · High confidence
Also notable
Ends Jun 2035 · High confidence
Also notable
Ends Jun 2035 · High confidence
Also notable
Ends Sep 2034 · High confidence
Also notable
Ends Jun 2035 · High confidence
Also notable
Ends Jan 2038 · High confidence
Also notable
Ends May 2037 · High confidence
Also notable
Ends Sep 2034 · High confidence
Methods, Devices and Systems for Pulmonary Delivery of Active Agents
US 11,298,477
Cited by 34 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2038.
Flow Regulating Inhaler Device
US 10,166,349
Cited by 51 later US patents, top 5% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2035.
Drug Dose Cartridge for an Inhaler Device
US 10,099,020
Cited by 84 later US patents, top 5% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2035.
Method and System for Drug Delivery
US 9,775,379
The most cited patent in this portfolio, cited by 289 later US patents, top 1% of utility patents granted in 2017 in our data. Protection runs to 2034.
Method and Device for Vaporization and Inhalation of Isolated Substances
US 10,080,851
Cited by 95 later US patents, top 5% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2035.
Personal Vaporizing Device with Slidable Cart
US 11,229,758
Cited by 33 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2038.
Low Dose Therapeutic Treatment
US 11,806,331
Cited by 11 later US patents, top 10% of utility patents granted in 2023 in our data. Protection runs to 2037.
Inhaler
US D858,745
Cited by 31 later US patents, top 25% of design patents granted in 2019 in our data. Protection runs to 2034.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 6, 2027The maintenance fee for Flow Regulating Inhaler Device (US 10,369,304) comes due Feb 6, 2027. Unpaid by Aug 6, 2027, it lapses early.
- 1 fee due Mar 26, 2027The maintenance fee for Method and System for Drug Delivery (US 11,766,399) comes due Mar 26, 2027. Unpaid by Sep 27, 2027, it lapses early.
- 1 fee due May 7, 2027The maintenance fee for Low Dose Therapeutic Treatment (US 11,806,331) comes due May 7, 2027. Unpaid by Nov 8, 2027, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 22, 2026
What they patent
The largest of its 11 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Flow Regulating Inhaler Device | 5 in force | to Oct 2036 |
| Methods, Devices and Systems for Pulmonary Delivery of Active Agents | 4 in force | to Jan 2038 |
| Drug Dose Cartridge for an Inhaler Device | 4 in force | to Apr 2037 |
| Method and System for Drug Delivery | 3 in force | to Sep 2034 |
| Personal Vaporizing Device with Slidable Cart | 2 in force | to Jan 2038 |
| Method and Device for Vaporization and Inhalation of Isolated Substances | 2 in force | to Jan 2038 |
| Low Dose Therapeutic Treatment | 2 in force | to May 2037 |
| Cartridge Unit Coupler | 1 in force | to Nov 2042 |
| Replaceable Flow Tract for an Inhaler | 1 in force | to Apr 2042 |
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,766,399 | Method and System for Drug Delivery In force · High confidence | In force | High confidence | |
| US 11,071,712 | Method and System for Drug Delivery In force · High confidence | In force | High confidence | |
| US D857,879 | Inhaler Cartridge In force · High confidence | In force | High confidence | |
| US D858,745 | Inhaler In force · High confidence | In force | High confidence | |
| US 9,775,379 | Method and System for Drug Delivery In force · High confidence | In force | High confidence | |
| US 9,802,011 | Drug Dose Cartridge for an Inhaler Device In force · High confidence | In force | High confidence | |
| US 9,839,241 | Methods, Devices and Systems for Pulmonary Delivery of Active Agents In force · High confidence | In force | High confidence | |
| US 9,993,602 | Flow Regulating Inhaler Device In force · High confidence | In force | High confidence | |
| US 10,080,851 | Method and Device for Vaporization and Inhalation of Isolated Substances In force · High confidence | In force | High confidence | |
| US 10,099,020 | Drug Dose Cartridge for an Inhaler Device In force · High confidence | In force | High confidence |
Also on record, not counted in the 26: 3 patents in force now held by others · 17 applications pending · 4 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.